SEC v. Zhuobin Hong et al: Complaint

Complaint alleging insider trading in the securities of Delaware-domiciled Sagent Pharmaceuticals, Inc. using “Hong Kong-based trading accounts held in the names of China-based relatives” in U. S. Securities and Exchange Commission v. Zhuobin Hong, a.k.a. Ben Hong, and Caixia Jiang, both described as former residents of California currently residing in China, as Defendants, and Zhuoyan Hong and Haotao Jiang, both of China, as Relief Defendants, at the U. S. District Court for the Central District of California.

- You’re only seeing part of this content
  
  To view the entire article or download the document, subscribe today.
  
  – Offshore Courts: 29,000+ court cases (Bahamas, Bermuda, BVI, Cayman Islands)
  – Investigative Articles: 4,500+ in-depth articles, including fraud exposés
  – MLATs – Criminal: 1,400+ MLATs on global criminal investigations
  – Ch. 15 – Insolvencies: Monitored daily
  – Foreign Discovery: Applications for foreign discovery filed in the USA, monitored daily
  – Regulatory Actions: Global regulatory actions, fines, and bans, monitored daily
  – And More: Criminal indictments, extraditions, winding-up petitions, and more
  
  Unlimited access for less than $3/day.
  
  Cancel anytime.
  
  SUBSCRIBE
- SIGN IN
  
  Forgot your password?

Pages: 21

Date: May 04, 2020

Defendants/Respondents: Zhuobin Hong, Caixia Jiang, Zhuoyan Hong, Haotao Jiang

Plaintiffs/Applicants: U. S. Securities and Exchange Commission

Case Number: Xx Xx Xx

Topic: Investment, Listed Securities, Regulatory

Allegation: Fraud

Topics

Listed Securities Regulatory USA

[ 3 more... ] [ top 5 ]

Keywords

Ben Hong Caixia Jiang Haotao Jiang Nichi-Iko Pharmaceutical Co., Ltd. Sagent Pharmaceuticals, Inc.

U. S. Securities and Exchange Commission Zhuobin Hong Zhuoyan Hong

[ 3 more... ] [ top 5 ]

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.